Search

everythinglearnresearchcommunity

for

Search:↓

Erythropoietin overexpression disrupts hair growth and fat formation in mice.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

Researchers found a new gene, hacl-1, that is active in mouse hair follicles during hair growth and may be important for hair biology.

A specific gene mutation causes congenital hair loss.

Hedgehog pathway inhibitors could be effective in treating melanoma.

Blocking mTORC1 activity with rapamycin could help increase hair pigmentation and growth, potentially reversing gray hair.

Epiregulin can help hair grow and may be useful for treating hair loss.

Reduced TRPS1 leads to increased STAT3 and SOX9 in hair follicles, affecting hair growth.

Recent findings advanced understanding of cancer mechanisms and potential treatments.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

Overexpressing ATF3 in mice's epithelial cells may lead to oral cancer.

Vitamin D receptor can control the hairless gene linked to hair loss even without vitamin D.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

A mutation in the HR gene causes a rare form of irreversible hair loss in two Kashmiri families. Whole exome sequencing is effective for finding such mutations.

Dermal fibroblasts have adjustable roles in wound healing, with specific cells promoting regeneration or scar formation.

Antizyme slows skin tumor growth by reducing cell growth in mice.

A mutation in the iRhom2 gene causes hairless mice due to abnormal hair follicle development.

The HR protein's role as a repressor is essential for controlling hair growth.

A new gene mutation linked to Olmsted syndrome may increase cancer risk, suggesting the need for ongoing patient monitoring.

Krox20 overexpression in fibroblasts may play a role in abnormal scar formation and could be a target for new treatments.

Thyrotropin-releasing hormone may help control skin and hair growth and could aid in treating related disorders.

The near-naked hairless mutation causes hair loss but is not due to a mutation in the hairless gene itself.

GLI and EGF signalling affect Basal Cell Carcinoma development and could be therapeutic targets.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Krox20 is important for maintaining stem cells in the skin and affects hair growth and color.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

A woman's male-pattern facial hair growth was caused by a rare malignant ovarian tumor that was difficult to diagnose and treat.